Eisai opens sales, marketing operation in Netherlands
Eisai‘s sales and marketing operation will initially market epilepsy treatment drug Zonegran (zonisamide) in the Netherlands. Eisai Netherlands managing director Gert-Jan Kouseband said Eisai’s entry into the country
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.